Legal Representation
Attorney
David Toren
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 6, 2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 9, 2002 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Nov 20, 2001 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 28, 2001 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 8, 2001 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Mar 28, 2001 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 22, 2001 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| Feb 26, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide for the treatment of cardiovascular diseases including high blood pressure, congestive heart failure, diabetic nephropathy, atherosclerosis and stroke
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HCT"